Page 23 - EVALUATION OF TREATMENT FOR HEAVY MENSTRUAL BLEEDING by Herman, Malou
P. 23
Pictorial Blood Assessment Chart and endometrial ablation outcome
7
85
Table 1: Baseline characteristics of the included studies. Data are in numbers (n), years , mean (±standard deviation) or median (min-max).
Study
Technique
Frequency Age (n) (years)
PBAC PBAC Baseline 12 months
PBAC
12 months median
PBAC
12 months 75th percentile
Satisfied Re-intervention after women initial treatment
(%) (%)
Abbott ‘02
NovaSure
Cavaterm balloon 18
453 88
8 (0-1720)
62
87% 9%
Bongers ‘04
43 43 30 46
731 86
10 (0-1480)
68
86% 7%
Brun ‘06
Cavatherm balloon
503 46
19 (0-410)
54
95% 0%
Busfield ‘05
Thermablate
41 41
502 110
79 (3-465)
149
- 19%
Cooper ‘04 Hawe ‘03
209 40 1 42
453 10 353 29
0 (0-248) 4 (0-251)
4 34
98% 1% 81% 16%
Meyer ‘98 Penninx ‘10
Thermachoice
NovaSure
Hydrothermal Ablation 78
553 53 797 173
21 (0-457) 21 (0-2500)
61 100
94% 2% 78% 16%
Penninx ‘13*
NovaSure
Thermablate 52
944 98
14 (0-1450)
94
82% 9%
Total
900 42
(±5.3) (±567)
77
(± 211)
7 (0-2500)
89% 7%
PBAC = Pictorial Blood Assessment Chart * Unpublished data
Thermachoice
NovaSure 83
Microwave
Laser
Cavaterm balloon 37
37 41
137 40 82 45
52 45
630
mean
